Loss of lncRNA LINC01056 leads to sorafenib resistance in HCC

Sorafenib is a major nonsurgical option for patients with advanced hepatocellular carcinoma (HCC); however, its clinical efficacy is largely undermined by the acquisition of resistance. The aim of this study w...

Source: Molecular Cancer - April 6, 2024 Category: Cancer & Oncology Authors: Yau-Tuen Chan, Junyu Wu, Yuanjun Lu, Qiucheng Li, Zixin Feng, Lin Xu, Hongchao Yuan, Tingyuan Xing, Cheng Zhang, Hor-Yue Tan, Yibin Feng and Ning Wang Tags: Research Source Type: research